Search Results - "Richey, Sylvia S."

Implementation of an EHR-embedded decision support tool in community oncology practices by Maniago, Rebecca, Richey, Sylvia S., DeVincenzo, Sarah, Jou, Stephanie, Linzmayer, Robin, Donegan, Janet, Calip, Gregory Sampang, Altomare, Ivy

“…Abstract only 274 Background: Clinical decision support (CDS) tools facilitate value based cancer care delivery and can enable measurement of guideline…”
Get full text

Use of antiemetic prophylaxis and oral breakthrough medication for highly emetogenic chemotherapy (HEC) in a large community oncology network by Young, Garrett, Schleicher, Stephen Matthew, Arrowsmith, Edward, McCullough, Stacey, Richey, Sylvia S., Blakely, Johnetta, Dickson, Natalie R., Schwartzberg, Lee S.

“…Abstract only 253 Background: Prophylaxis for highly emetogenic chemotherapy (HEC) is well established in clinical guidelines, but real-world treatment…”
Get full text

Using an ePRO tool to help meet quality metric reporting standards: Screening for tobacco usage and falls risk by Buzaglo, Joanne S., Stepanski, Edward, Joiner, Mary, Taylor, Deb, Musallam, Alexander, Richey, Sylvia S., Schwartzberg, Lee S., Vanderwalde, Ari M., Decker, Veronica B.

“…Abstract only e19191 Background: ASCO has implemented the Quality Oncology Practice Initiative (QOPI), a certification program established to evaluate oncology…”
Get full text

Feasibility of and associated cost savings from transitioning to therapeutic biosimilar use in a large community oncology network by Young, Garrett, McGee, Kathy, Owens, Leah, McCullough, Stacey, Arrowsmith, Edward, Poole, Stacey L, Marsden, Mary Catherine, Lyss, Aaron J., Schleicher, Stephen Matthew, Richey, Sylvia S., Dickson, Natalie R., Schwartzberg, Lee S.

“…Abstract only 9 Background: The use of biosimilar drugs in the treatment of cancer offer an opportunity for oncology providers to decrease total cost of care…”
Get full text